Skip to main content
. 2021 Jul 6;9(7):751. doi: 10.3390/vaccines9070751

Figure 3.

Figure 3

IFNγ ELISPOT results obtained in stimulated PBMCs from blood collected during the study with UV inactivated pdm09 H1N1 A/Human/Catalonia/063/2009 (A); recombinant HA1 (B) and NG34 peptide (C).